new semaglutide pill Best Options for 2026: Oral Wegovy Approved by FDA as Patients Compare Injectable and Compounded Access Pathways Novo Nordisk to Seek Approval

Adigestive enzymes supplementprovides exogenous enzymes that complement your body's own production, ensuring food is properly broken downbeforeit reaches the lower intestine

Expanding GLP-1 pipeline globally Amgen Inc

Passing gastrointestinal updates, including mild constipation, transient diarrhea, or brief bouts of bloating/acid reflux

glp-1 glp-1

New Data: Phase 3 TRIUMPH-4 Results (Retatrutide) Eli Lilly just released topline results from the Phase 3 TRIUMPH-4 trial, evaluating the triple hormone receptor agonist retatrutide in patients with obesity and knee osteoarthritis (OA)

Evidence, safety, and NHS treatment pathways explained.